Katie Waldo - McDermott+Consulting

Overview


Katie is an experienced government relations strategist who helps clients navigate the complex issues surrounding Medicare, Medicaid and the healthcare marketplace.

Katie works with clients to represent their needs before the US Congress and the US Department of Health and Human Services (HHS) and its agencies by relying on extensive experience as a policy advisor on the Medicaid and Medicare programs, as well as the 340B program and other aspects of the Public Health Service Act. She anticipates the effects of state and federal policymaking on issues impacting their businesses and crafts proactive and comprehensive legislative strategies.

Katie served as a senior analyst at the Medicaid and CHIP Payment and Access Commission (MACPAC), where she developed policy recommendations and conducted legislative analyses related to Medicare and Medicaid issues in support of Congress and HHS. At MACPAC, Katie regularly interpreted and analyzed large data sets for reports.

Prior to her work with MACPAC, Katie served in Senator Chuck Grassley’s (R-IA) office as a health policy fellow where she conducted research and analyses on health policy options. She also worked at George Washington University, where she led the Teaching Health Center Graduate Medical Education evaluation.

Education


George Washington University, M.P.H.

Boston University, B.S.

Representative Experience


  • Led responses to congressional inquiries and preparation efforts for congressional testimony
  • Led several federal strategic planning efforts focusing on developing federal advocacy efforts, issue priorities and policy analysis
  • Led efforts on building and maintaining relationship with members and staff to increase profiles and presence on Capitol Hill
  • Led evaluations of the Financial Alignment Initiative and the Teaching Health Center Graduate Medical Education program
  • Presented and serves as authoritative resource on related health policy, including Medicaid, Marketplace and Medicare policy

Insights and In the News


Consolidated Appropriations Act, 2023: Health Provisions

Way Too Early Preview: What the Midterm Election Results Might Mean for ...

CMS Releases CY 2023 Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems ...

Post-Election Committee Membership Tracker

Lame Duck Preview 2022

The Inflation Reduction Act of 2022: Healthcare Provisions Updated: 08/16/2022

CMS Releases FY 2023 IPPS Final Rule

CMS Releases CY 2023 Outpatient Prospective Payment System and Ambulatory Surgical Center Payment ...

CMS Releases FY 2023 IPPS Proposed Update

President’s FY 2023 Budget: HHS Highlights

Interim Final Rule with comment (IFR) to Surprise Billing; Part II

Health Policy Breakroom - Ep 75 No Surprises Billing Act 1 day ago1 day ...

Requirements Related to Surprise Billing; Part I: Policy Update

President’s Fiscal Year 2022 Budget: What You Need to Know

Health Policy Breakroom Ep. 66 - The American Families Plan

Health Policy Breakroom Ep. 65 - CMS Reverses Texas Medicaid Waiver

2021 Legislative Calendar (Updated March 2021)

American Rescue Plan Act of 2021: Key Healthcare Provisions

Health Policy Breakroom Ep. 60 - The American Rescue Plan

117th Congress: Leadership and Health Committee Membership

Health Policy Breakroom Ep. 56 - Surprise Billing in the Consolidated Appropriations Act

Surprise Billing in the Consolidated Appropriations Act, 2021: Details and Analysis of Process

The First 100 Days: Biden's Healthcare Outlook

Summary of Key Health Provisions in the Consolidated Appropriations Act, 2021

Trump Executive Order Tracker

Drug Pricing – Trump Administration Announces Most-Favored Nation Drug Pricing Model

Show More

Katie Waldo

Insights & Events / Media

No results using the selected filter(s)